Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA)

BACKGROUND: Docosahexaenoic acid (DHA) is a natural compound with anticancer and anti-angiogenesis activity that is currently under investigation as both a preventative agent and an adjuvant to breast cancer therapy. However, the precise mechanisms of DHA’s anticancer activities are unclear. It is u...

Descripción completa

Detalles Bibliográficos
Autores principales: Hannafon, Bethany N., Carpenter, Karla J., Berry, William L., Janknecht, Ralf, Dooley, William C., Ding, Wei-Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504101/
https://www.ncbi.nlm.nih.gov/pubmed/26178901
http://dx.doi.org/10.1186/s12943-015-0400-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504101/
https://www.ncbi.nlm.nih.gov/pubmed/26178901
http://dx.doi.org/10.1186/s12943-015-0400-7

Ejemplares similares